Article

Peripartum myocardial ischemia: A review of Canadian deliveries from 1970 to 1998

Department of Anesthesia, University of Calgary, Calgary, Canada.
American journal of obstetrics and gynecology (Impact Factor: 3.97). 05/2006; 194(4):1027-33. DOI: 10.1016/j.ajog.2005.10.795
Source: PubMed

ABSTRACT The purpose of this study was to evaluate the incidence of peripartum myocardial ischemia in Canada.
We identified the cohort of women who were admitted to Canadian hospitals for delivery between 1970 and 1998 to calculate the incidence rate and to evaluate potential risk factors.
One hundred fourteen of 10,032,375 women delivered in Canadian hospitals between 1970 and 1998 had peripartum myocardial ischemia recorded as a discharge diagnosis. The overall crude incidence rate was 1.1 (95% confidence interval 0.93, 1.37) women with peripartum myocardial ischemia per 100,000 women delivering per year as noted in the Canadian Hospital Morbidity database. Rates did not increase over time but increased with maternal age. Identified risk factors were diabetes mellitus, hyperlipidemia, and chronic heart disease. The case fatality rate among women with the disease was 1.8%.
The incidence of peripartum myocardial ischemia did not increase between 1970 and 1998 in Canada, despite an aging cohort with more prevalent medical comorbidities. Maternal mortality from this event is lower than previously described.

0 Bookmarks
 · 
50 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Myocardial infarction is a very rare complication with a 7% mortality rate, during pregnancy, but the incidence increases with the age of the parturient. Coronary artery dissection is a more and more frequent mechanism. Elevated troponin plasma concentration is a specific diagnostic tool in front of atypical symptoms. In pregnant women suffering from coronary artery disease, treatment must be continued except for antagonists of the renin angiotensin receptors. Antiplatelets agents must be interrupted before C-section or epidural. Fibrinolysis for myocardial infarction is contra-indicated by pregnancy, bare stenting is possible to avoid prolonged treatment with antiplatelet agents
    Le Praticien en Anesthésie Réanimation 09/2013; 17(4):174–179. DOI:10.1016/j.pratan.2013.07.008
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute myocardial infarction (AMI) is a rare but often catastrophic event during pregnancy, delivery or puerperium, leading to a high mortality rate. It has different pathogenic mechanisms, such as atherosclerosis, vasospasm, thrombosis and coronary dissection. Although MI has been reported in pregnant women at all stages of pregnancy and postpartum, it occurs more commonly in the third trimester and most commonly involves the anterior wall. Evidence suggests that pregnancy itself is an independent risk factor for MI, conferring a three- to four-fold higher risk than that of nonpregnant women matched for age, possibly due to the unique physiological changes required to meet the demands of a growing foetus. We report a case of a 27-year-old woman with familial hyperlipidaemia presenting with myocardial infarction six days after caesarean delivery, secondary to severe left main coronary stenosis (LMCA), who was treated with emergency coronary artery bypass grafting (CABG).
    06/2013; 24(4):e13-6. DOI:10.5830/CVJA-2013-016
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Cardiac disease is the leading cause of maternal death. Non-fatal ischemic events may go unnoted during the time of delivery. The aim of this study was to assess the incidence of subclinical myocardial ischemia amongst parturients, as evidenced by a raised troponin assay in the postpartum period. Methods We undertook a prospective observational pilot study in a tertiary obstetric hospital with over 7000 deliveries a year. Targeted sampling was used to enter subjects in pre-defined high- or low-risk groups for myocardial strain, according to their clinical history and a brief questionnaire. Troponin T levels of 140 women were assessed between 8 and 24 h postpartum. Results Ninety-one women considered to be at high risk and 49 at low risk women for myocardial strain were enrolled. The overall mean (± SD) serum troponin T level at 24 h postpartum was 8.7 ± 19.7 ng/L (normal range <14 ng/L). The incidence of a positive troponin result was 4.3% (95% CI 1.6, 9.1). Four patients (8.2%) of the low-risk group and two (2.2%) in the high-risk group had elevated troponin T assays. Conclusion This study found that 4% of women had elevated postpartum troponin assays, within levels in the range suggestive of myocardial damage. However, we were unable to ascertain how to identify this group of women prospectively. At this time, we recommend a low threshold for investigation should be maintained.
    International Journal of Obstetric Anesthesia 07/2014; 24(1). DOI:10.1016/j.ijoa.2014.07.005 · 1.83 Impact Factor